DOUBLE-BLIND TRIAL OF TRANSFER-FACTOR VS PLACEBO IN MULTIPLE-SCLEROSIS PATIENTS

被引：0
|
作者：
COLLINS, RC
ESPINOZA, LR
PLANK, CR
EBERS, GC
ROSENBERG, RA
ZABRISKIE, JB
机构：
[1] ROCKEFELLER UNIV,NEW YORK,NY 10021
[2] COLUMBIA UNIV,COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032
[3] ROYAL VICTORIA HOSP,DIV IMMUNOL & RHEUMATOL,MONTREAL 112,QUEBEC,CANADA
[4] WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63130
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1978年 / 33卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1 / 11
页数：11
相关论文
共 50 条
  • [41] TRANSFER-FACTOR TREATMENT OF MULTIPLE-SCLEROSIS - PILOT-STUDY
    FOG, T
    JERSILD, C
    PLATZ, P
    SVEJGAARD, A
    PEDERSEN, L
    KAMHANSEN, S
    RAUN, N
    MELLERUP, E
    JACOBSEN, B
    LINNEMANN, F
    WESTH, P
    ACTA NEUROLOGICA SCANDINAVICA, 1977, 55 : 253 - 264
  • [42] DOUBLE-BLIND CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL REPORT
    MERTIN, J
    KREMER, M
    KNIGHT, SC
    BATCHELOR, JR
    HALLIDAY, AM
    RUDGE, P
    HEALEY, MJR
    COMPSTON, A
    THOMPSON, EJ
    DENMAN, M
    MEDAWAR, PB
    LANCET, 1982, 2 (8294): : 351 - 354
  • [43] DOUBLE-BLIND TRIAL OF DEXAMETHASONE VERSUS METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS ACUTE RELAPSES
    LAMANTIA, L
    EOLI, M
    MILANESE, C
    SALMAGGI, A
    DUFOUR, A
    TORRI, V
    EUROPEAN NEUROLOGY, 1994, 34 (04) : 199 - 203
  • [44] DOUBLE-BLIND TRIAL WITH BACLOFEN (LIORESAL) AND DIAZEPAM IN SPASTICITY DUE TO MULTIPLE-SCLEROSIS
    FROM, A
    HELTBERG, A
    ACTA NEUROLOGICA SCANDINAVICA, 1975, 51 (02): : 158 - 166
  • [45] Intravenous immunoglobulin in multiple sclerosis: A multicenter double-blind, placebo controlled trial
    Achiron, A
    Gabbay, U
    Gilad, R
    Hassin, S
    Barak, Y
    Gornish, M
    Ziv, I
    Goldhamer, Y
    Elizur, A
    Rotstein, Z
    Noy, S
    Miron, S
    SarovaPinhas, I
    NEUROLOGY, 1996, 46 (02) : 52001 - 52001
  • [46] 4-AMINOPYRIDINE IMPROVES NEUROLOGICAL DEFICITS IN MULTIPLE-SCLEROSIS PATIENTS - DEMONSTRATION IN A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    BEVER, CT
    YOUNG, D
    ANDERSON, P
    KRUMHOLZ, A
    CONWAY, K
    LESLIE, J
    EDDINGTON, N
    PLAISANCE, K
    PANITCH, H
    JOHNSON, K
    ROSENBERG, L
    DEVANE, J
    NEUROLOGY, 1992, 42 (07) : 1427 - 1427
  • [47] HYPERBARIC-OXYGEN AND MULTIPLE-SCLEROSIS - SHORT-TERM RESULTS OF A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    BARNES, MP
    CARTLIDGE, NEF
    BATES, D
    FRENCH, JM
    SHAW, DA
    LANCET, 1985, 1 (8424): : 297 - 300
  • [48] A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF 3,4 DIAMINOPYRIDINE IN THE SYMPTOMATIC TREATMENT OF MULTIPLE-SCLEROSIS
    CARTER, JL
    STEVENS, JC
    SMITH, B
    CASELLI, RJ
    METCALF, A
    WINDEBANK, A
    ZINSMEISTER, A
    RODRIGUEZ, M
    ANNALS OF NEUROLOGY, 1993, 34 (02) : 272 - 273
  • [49] MODULATION OF IMMUNITY IN MULTIPLE-SCLEROSIS - A DOUBLE-BLIND LEVAMISOLE-PLACEBO CONTROLLED-STUDY IN 85 PATIENTS
    GONSETTE, RE
    DEMONTY, L
    DELMOTTE, P
    DECREE, J
    DECOCK, W
    VERHAEGHEN, H
    SYMOENS, J
    JOURNAL OF NEUROLOGY, 1982, 228 (01) : 65 - 72
  • [50] TRANSFER-FACTOR AND HEPATITIS-B - DOUBLE-BLIND STUDY
    ELLISPEGLER, R
    SUTHERLAND, DC
    DOUGLAS, R
    WOODFIELD, DG
    WILSON, JD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1979, 36 (02): : 221 - 226
12345